Related Experiment Video
Updated: Feb 2, 2026

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
Hemodynamic changes after acute fluid loading in patients with systemic sclerosis without pulmonary hypertension
Michele D'Alto1, Emanuele Romeo1, Paola Argiento1
11 Cardiology, University "L. Vanvitelli" - Monaldi Hospital, Naples, Italy.
Systemic sclerosis patients without pulmonary hypertension show exaggerated pulmonary vascular pressure increases and reduced cardiac output after a fluid challenge, suggesting subclinical left ventricular diastolic dysfunction.
Area of Science:
- Cardiology
- Pulmonology
- Rheumatology
Background:
- Systemic sclerosis (SSc) is associated with biventricular dysfunction.
- Pulmonary hypertension (PH) discrimination relies on fluid challenges.
- Subclinical cardiac dysfunction is common in SSc.
Purpose of the Study:
- To assess hemodynamic responses to fluid challenges in SSc patients without PH.
- To investigate pulmonary circulation changes after acute volume loading in SSc.
- To identify early signs of cardiac dysfunction in SSc.
Main Methods:
- Right heart catheterization in 25 SSc patients and 25 controls.
- Basal hemodynamic measurements followed by saline fluid challenge (7 mL/kg).
- Comparison of pulmonary artery pressures, wedge pressure, and cardiac index before and after fluid loading.
Main Results:
- No baseline hemodynamic differences between SSc patients and controls.
- SSc patients exhibited significantly greater increases in right atrial pressure, mean pulmonary artery pressure, and pulmonary artery wedge pressure post-fluid challenge.
- SSc patients showed a smaller increase in cardiac index compared to controls.
- Pulmonary vascular resistance remained similar between groups.
- Four SSc patients and one control exceeded a pulmonary artery wedge pressure of 18 mmHg.
Conclusions:
- SSc patients without overt PH demonstrate heightened pulmonary vascular pressure response and diminished cardiac output augmentation after fluid loading.
- These findings suggest underlying subclinical left ventricular diastolic dysfunction in SSc patients.
- Fluid challenges can reveal latent cardiac abnormalities in SSc, aiding in early diagnosis and management.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Overview of Systemic and Pulmonary Circulation
The oxygenated blood is sent...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

